Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India?
作者信息
Tempe Deepak K
机构信息
Visting Professor, Institute of Liver and Biliary Sciences, Former Dean and Professor of Excellence, Maulana Azad Medical College, Institute of Liver and Biliary Sciences, New Delhi 110002, India.
出版信息
Lancet Infect Dis. 2021 Oct;21(10):1349-1350. doi: 10.1016/S1473-3099(21)00450-3. Epub 2021 Aug 24.
Abstract
摘要
相似文献
1
Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India?
Lancet Infect Dis. 2021 Oct;21(10):1349-1350. doi: 10.1016/S1473-3099(21)00450-3. Epub 2021 Aug 24.
2
Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India? - Authors' reply.
Lancet Infect Dis. 2021 Oct;21(10):1350. doi: 10.1016/S1473-3099(21)00480-1. Epub 2021 Aug 24.
3
Outcomes in neonates born to mothers with COVID-19 during the second wave in India.
Eur J Pediatr. 2022 Sep;181(9):3537-3543. doi: 10.1007/s00431-022-04546-0. Epub 2022 Jul 8.
4
Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India.
Front Public Health. 2022 Apr 4;10:836454. doi: 10.3389/fpubh.2022.836454. eCollection 2022.
5
Second wave of COVID-19 in India: Dissection of the causes and lessons learnt.
Travel Med Infect Dis. 2021 Sep-Oct;43:102126. doi: 10.1016/j.tmaid.2021.102126. Epub 2021 Jun 16.
6
Containment strategies for COVID-19 in India: lessons from the second wave.
Expert Rev Anti Infect Ther. 2022 Jun;20(6):829-835. doi: 10.1080/14787210.2022.2036605. Epub 2022 Feb 7.
7
India grapples with second wave of COVID-19.
Lancet Microbe. 2021 Jun;2(6):e238. doi: 10.1016/S2666-5247(21)00123-3. Epub 2021 Jun 2.
8
Evaluation of symptoms along with depression, anxiety and stress levels of Sars-CoV-2 positive patients during the second wave in the city of Indore, Central India - a cross sectional study.
Przegl Epidemiol. 2022;76(3):296-303. doi: 10.32394/pe.76.28.
9
Vaccine certificate during domestic traveling: a potential initiative to prevent COVID-19 waves in India.
Hum Vaccin Immunother. 2021 Oct 3;17(10):3487-3488. doi: 10.1080/21645515.2021.1936862. Epub 2021 Jun 25.
10
Impact of second wave covid-19 on children in India.
Child Abuse Negl. 2021 Jul;117:105116. doi: 10.1016/j.chiabu.2021.105116. Epub 2021 May 14.
本文引用的文献
1
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.
Am J Ther. 2021 Apr 22;28(3):e299-e318. doi: 10.1097/MJT.0000000000001377.
2
Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India.
Lancet Infect Dis. 2021 Jul;21(7):905-907. doi: 10.1016/S1473-3099(21)00329-7. Epub 2021 Jun 8.
3
Clinical Triage in a Large 2000-Bed COVID-19 Care Facility: Role of the Anesthesiologist.
J Cardiothorac Vasc Anesth. 2021 Sep;35(9):2827-2830. doi: 10.1053/j.jvca.2021.01.047. Epub 2021 Jan 29.
4
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial.
Int J Infect Dis. 2021 Feb;103:62-71. doi: 10.1016/j.ijid.2020.11.142. Epub 2020 Nov 16.
5
Frauds in scientific research and how to possibly overcome them.
J Med Ethics. 2020 Oct 6. doi: 10.1136/medethics-2020-106639.
Zotero 插件